[1]
Mai PL, Chen BE, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Bodrogi I, Geczi L, Olah E, Heimdal K, Fosså SD, Nathanson KL, Korde L, Easton DF, Dudakia D, Huddart R, Stratton MR, Bishop DT, Rapley EA, Greene MH. Younger age-at-diagnosis for familial malignant testicular germ cell tumor. Familial cancer. 2009:8(4):451-6. doi: 10.1007/s10689-009-9264-6. Epub 2009 Jul 17
[PubMed PMID: 19609727]
[2]
Smith ZL, Werntz RP, Eggener SE. Testicular Cancer: Epidemiology, Diagnosis, and Management. The Medical clinics of North America. 2018 Mar:102(2):251-264. doi: 10.1016/j.mcna.2017.10.003. Epub 2017 Dec 21
[PubMed PMID: 29406056]
[3]
Cheriyan SK, Nicholson M, Aydin AM, Azizi M, Peyton CC, Sexton WJ, Gilbert SM. Current management and management controversies in early- and intermediate-stage of nonseminoma germ cell tumors. Translational andrology and urology. 2020 Jan:9(Suppl 1):S45-S55. doi: 10.21037/tau.2019.05.14. Epub
[PubMed PMID: 32055485]
[4]
Borni M, Kolsi F, Kammoun B, Kallel R, Souissi G, Boudawara MZ. Testicular non-seminomatous germ cell tumors (NSGCT) and brain metastases: About a rare location of the posterior fossa. Urology case reports. 2018 Nov:21():61-63. doi: 10.1016/j.eucr.2018.08.025. Epub 2018 Sep 4
[PubMed PMID: 30211008]
Level 3 (low-level) evidence
[5]
Goldberg H, Klaassen Z, Chandrasekar T, Fleshner N, Hamilton RJ, Jewett MAS. Germ Cell Testicular Tumors-Contemporary Diagnosis, Staging and Management of Localized and Advanced disease. Urology. 2019 Mar:125():8-19. doi: 10.1016/j.urology.2018.12.025. Epub 2018 Dec 28
[PubMed PMID: 30597167]
[6]
Cheng L, Albers P, Berney DM, Feldman DR, Daugaard G, Gilligan T, Looijenga LHJ. Testicular cancer. Nature reviews. Disease primers. 2018 Oct 5:4(1):29. doi: 10.1038/s41572-018-0029-0. Epub 2018 Oct 5
[PubMed PMID: 30291251]
[7]
Einhorn LH. Treatment of testicular cancer: a new and improved model. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1990 Nov:8(11):1777-81
[PubMed PMID: 1700077]
[8]
Jørgensen N, Rajpert-De Meyts E, Main KM, Skakkebaek NE. Testicular dysgenesis syndrome comprises some but not all cases of hypospadias and impaired spermatogenesis. International journal of andrology. 2010 Apr:33(2):298-303. doi: 10.1111/j.1365-2605.2009.01050.x. Epub 2010 Feb 4
[PubMed PMID: 20132348]
Level 3 (low-level) evidence
[9]
Lip SZ, Murchison LE, Cullis PS, Govan L, Carachi R. A meta-analysis of the risk of boys with isolated cryptorchidism developing testicular cancer in later life. Archives of disease in childhood. 2013 Jan:98(1):20-6. doi: 10.1136/archdischild-2012-302051. Epub 2012 Nov 28
[PubMed PMID: 23193201]
Level 1 (high-level) evidence
[10]
Harland SJ. Conundrum of the hereditary component of testicular cancer. Lancet (London, England). 2000 Oct 28:356(9240):1455-6
[PubMed PMID: 11081522]
[11]
Hemminki K, Chen B. Familial risks in testicular cancer as aetiological clues. International journal of andrology. 2006 Feb:29(1):205-10
[PubMed PMID: 16466541]
[12]
Del Risco Kollerud R, Ruud E, Haugnes HS, Cannon-Albright LA, Thoresen M, Nafstad P, Vlatkovic L, Blaasaas KG, Næss Ø, Claussen B. Family history of cancer and risk of paediatric and young adult's testicular cancer: A Norwegian cohort study. British journal of cancer. 2019 May:120(10):1007-1014. doi: 10.1038/s41416-019-0445-2. Epub 2019 Apr 10
[PubMed PMID: 30967648]
[14]
Hanna NH, Einhorn LH. Testicular cancer--discoveries and updates. The New England journal of medicine. 2014 Nov 20:371(21):2005-16. doi: 10.1056/NEJMra1407550. Epub
[PubMed PMID: 25409373]
[15]
Idrees MT, Ulbright TM, Oliva E, Young RH, Montironi R, Egevad L, Berney D, Srigley JR, Epstein JI, Tickoo SK, Members of the International Society of Urological Pathology Testicular Tumour Panel. The World Health Organization 2016 classification of testicular non-germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel. Histopathology. 2017 Mar:70(4):513-521. doi: 10.1111/his.13115. Epub 2016 Dec 23
[PubMed PMID: 27801954]
[16]
Greene MH,Kratz CP,Mai PL,Mueller C,Peters JA,Bratslavsky G,Ling A,Choyke PM,Premkumar A,Bracci J,Watkins RJ,McMaster ML,Korde LA, Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype. Endocrine-related cancer. 2010 Jun;
[PubMed PMID: 20228134]
[17]
AlDubayan SH, Pyle LC, Gamulin M, Kulis T, Moore ND, Taylor-Weiner A, Hamid AA, Reardon B, Wubbenhorst B, Godse R, Vaughn DJ, Jacobs LA, Meien S, Grgic M, Kastelan Z, Markt SC, Damrauer SM, Rader DJ, Kember RL, Loud JT, Kanetsky PA, Greene MH, Sweeney CJ, Kubisch C, Nathanson KL, Van Allen EM, Stewart DR, Lessel D, Regeneron Genetics Center (RGC) Research Team. Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors. JAMA oncology. 2019 Apr 1:5(4):514-522. doi: 10.1001/jamaoncol.2018.6477. Epub
[PubMed PMID: 30676620]
[18]
Gurney J, Shaw C, Stanley J, Signal V, Sarfati D. Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis. BMC cancer. 2015 Nov 11:15():897. doi: 10.1186/s12885-015-1905-6. Epub 2015 Nov 11
[PubMed PMID: 26560314]
Level 1 (high-level) evidence
[19]
Ghasemiesfe M, Barrow B, Leonard S, Keyhani S, Korenstein D. Association Between Marijuana Use and Risk of Cancer: A Systematic Review and Meta-analysis. JAMA network open. 2019 Nov 1:2(11):e1916318. doi: 10.1001/jamanetworkopen.2019.16318. Epub 2019 Nov 1
[PubMed PMID: 31774524]
Level 1 (high-level) evidence
[20]
Strohsnitter WC, Noller KL, Hoover RN, Robboy SJ, Palmer JR, Titus-Ernstoff L, Kaufman RH, Adam E, Herbst AL, Hatch EE. Cancer risk in men exposed in utero to diethylstilbestrol. Journal of the National Cancer Institute. 2001 Apr 4:93(7):545-51
[PubMed PMID: 11287449]
[21]
Tan IB, Ang KK, Ching BC, Mohan C, Toh CK, Tan MH. Testicular microlithiasis predicts concurrent testicular germ cell tumors and intratubular germ cell neoplasia of unclassified type in adults: a meta-analysis and systematic review. Cancer. 2010 Oct 1:116(19):4520-32. doi: 10.1002/cncr.25231. Epub
[PubMed PMID: 20578177]
Level 3 (low-level) evidence
[22]
Peterson AC, Bauman JM, Light DE, McMann LP, Costabile RA. The prevalence of testicular microlithiasis in an asymptomatic population of men 18 to 35 years old. The Journal of urology. 2001 Dec:166(6):2061-4
[PubMed PMID: 11696707]
Level 3 (low-level) evidence
[23]
Serter S, Gümüş B, Unlü M, Tunçyürek O, Tarhan S, Ayyildiz V, Pabuscu Y. Prevalence of testicular microlithiasis in an asymptomatic population. Scandinavian journal of urology and nephrology. 2006:40(3):212-4
[PubMed PMID: 16809262]
Level 3 (low-level) evidence
[24]
Middleton WD, Teefey SA, Santillan CS. Testicular microlithiasis: prospective analysis of prevalence and associated tumor. Radiology. 2002 Aug:224(2):425-8
[PubMed PMID: 12147838]
[25]
Nigam M, Aschebrook-Kilfoy B, Shikanov S, Eggener S. Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009. World journal of urology. 2015 May:33(5):623-31. doi: 10.1007/s00345-014-1361-y. Epub 2014 Jul 17
[PubMed PMID: 25030752]
[26]
Gajendran VK, Nguyen M, Ellison LM. Testicular cancer patterns in African-American men. Urology. 2005 Sep:66(3):602-5
[PubMed PMID: 16140086]
[27]
Skakkebaek NE, Berthelsen JG, Müller J. Carcinoma-in-situ of the undescended testis. The Urologic clinics of North America. 1982 Oct:9(3):377-85
[PubMed PMID: 6128821]
[28]
Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World journal of urology. 2004 Apr:22(1):2-14
[PubMed PMID: 15034740]
[29]
Wood HM, Elder JS. Cryptorchidism and testicular cancer: separating fact from fiction. The Journal of urology. 2009 Feb:181(2):452-61. doi: 10.1016/j.juro.2008.10.074. Epub 2008 Dec 13
[PubMed PMID: 19084853]
[30]
Akre O, Pettersson A, Richiardi L. Risk of contralateral testicular cancer among men with unilaterally undescended testis: a meta analysis. International journal of cancer. 2009 Feb 1:124(3):687-9. doi: 10.1002/ijc.23936. Epub
[PubMed PMID: 18973229]
[31]
Fosså SD, Chen J, Schonfeld SJ, McGlynn KA, McMaster ML, Gail MH, Travis LB. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men. Journal of the National Cancer Institute. 2005 Jul 20:97(14):1056-66
[PubMed PMID: 16030303]
[33]
Znaor A, Lortet-Tieulent J, Jemal A, Bray F. International variations and trends in testicular cancer incidence and mortality. European urology. 2014 Jun:65(6):1095-106. doi: 10.1016/j.eururo.2013.11.004. Epub 2013 Nov 14
[PubMed PMID: 24268506]
[34]
Ghazarian AA, Trabert B, Devesa SS, McGlynn KA. Recent trends in the incidence of testicular germ cell tumors in the United States. Andrology. 2015 Jan:3(1):13-8. doi: 10.1111/andr.288. Epub 2014 Oct 20
[PubMed PMID: 25331158]
[35]
Looijenga LH, Gillis AJ, Stoop H, Biermann K, Oosterhuis JW. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance. International journal of andrology. 2011 Aug:34(4 Pt 2):e234-51. doi: 10.1111/j.1365-2605.2011.01157.x. Epub 2011 May 12
[PubMed PMID: 21564133]
[36]
Hussain SA, Ma YT, Palmer DH, Hutton P, Cullen MH. Biology of testicular germ cell tumors. Expert review of anticancer therapy. 2008 Oct:8(10):1659-73. doi: 10.1586/14737140.8.10.1659. Epub
[PubMed PMID: 18925857]
[38]
Masterson TA, Cary C, Rice KR, Foster RS. The Evolution and Technique of Nerve-Sparing Retroperitoneal Lymphadenectomy. The Urologic clinics of North America. 2015 Aug:42(3):311-20. doi: 10.1016/j.ucl.2015.04.005. Epub 2015 Jun 6
[PubMed PMID: 26216818]
[39]
Ali TZ, Parwani AV. Benign and Malignant Neoplasms of the Testis and Paratesticular Tissue. Surgical pathology clinics. 2009 Mar:2(1):61-159. doi: 10.1016/j.path.2008.08.007. Epub 2009 Jan 27
[PubMed PMID: 26838100]
[40]
Alvarado-Cabrero I, Hernández-Toriz N, Paner GP. Clinicopathologic analysis of choriocarcinoma as a pure or predominant component of germ cell tumor of the testis. The American journal of surgical pathology. 2014 Jan:38(1):111-8. doi: 10.1097/PAS.0b013e3182a2926e. Epub
[PubMed PMID: 24145647]
[41]
Allen MS, Presentation and management of benign mediastinal teratomas. Chest surgery clinics of North America. 2002 Nov;
[PubMed PMID: 12471869]
[42]
Williamson SR, Delahunt B, Magi-Galluzzi C, Algaba F, Egevad L, Ulbright TM, Tickoo SK, Srigley JR, Epstein JI, Berney DM, Members of the ISUP Testicular Tumour Panel. The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel. Histopathology. 2017 Feb:70(3):335-346. doi: 10.1111/his.13102. Epub 2016 Dec 14
[PubMed PMID: 27747907]
[44]
Djaladat H, Burner E, Parikh PM, Beroukhim Kay D, Hays K. The Association Between Testis Cancer and Semen Abnormalities Before Orchiectomy: A Systematic Review. Journal of adolescent and young adult oncology. 2014 Dec 1:3(4):153-159
[PubMed PMID: 25538860]
Level 1 (high-level) evidence
[45]
Spermon JR, Kiemeney LA, Meuleman EJ, Ramos L, Wetzels AM, Witjes JA. Fertility in men with testicular germ cell tumors. Fertility and sterility. 2003 Jun:79 Suppl 3():1543-9
[PubMed PMID: 12801557]
[46]
Bosl GJ, Vogelzang NJ, Goldman A, Fraley EE, Lange PH, Levitt SH, Kennedy BJ. Impact of delay in diagnosis on clinical stage of testicular cancer. Lancet (London, England). 1981 Oct 31:2(8253):970-3
[PubMed PMID: 6117736]
[47]
Hotakainen K, Ljungberg B, Paju A, Rasmuson T, Alfthan H, Stenman UH. The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma. British journal of cancer. 2002 Jan 21:86(2):185-9
[PubMed PMID: 11870503]
[48]
Staples J. Alphafetoprotein, cancer, and benign conditions. Lancet (London, England). 1986 Nov 29:2(8518):1277
[PubMed PMID: 2431238]
[49]
Badia RR, Abe D, Wong D, Singla N, Savelyeva A, Chertack N, Woldu SL, Lotan Y, Mauck R, Ouyang D, Meng X, Lewis CM, Majmudar K, Jia L, Kapur P, Xu L, Frazier AL, Margulis V, Strand DW, Coleman N, Murray MJ, Amatruda JF, Lafin JT, Bagrodia A. Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management. The Journal of urology. 2021 Jan:205(1):137-144. doi: 10.1097/JU.0000000000001337. Epub 2020 Aug 28
[PubMed PMID: 32856980]
[50]
Stephenson A, Eggener SE, Bass EB, Chelnick DM, Daneshmand S, Feldman D, Gilligan T, Karam JA, Leibovich B, Liauw SL, Masterson TA, Meeks JJ, Pierorazio PM, Sharma R, Sheinfeld J. Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline. The Journal of urology. 2019 Aug:202(2):272-281. doi: 10.1097/JU.0000000000000318. Epub 2019 Jul 8
[PubMed PMID: 31059667]
[51]
Kreydin EI, Barrisford GW, Feldman AS, Preston MA. Testicular cancer: what the radiologist needs to know. AJR. American journal of roentgenology. 2013 Jun:200(6):1215-25. doi: 10.2214/AJR.12.10319. Epub
[PubMed PMID: 23701056]
[52]
Luz MA, Kotb AF, Aldousari S, Brimo F, Tanguay S, Kassouf W, Aprikian AG. Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor. World journal of surgical oncology. 2010 Nov 9:8():97. doi: 10.1186/1477-7819-8-97. Epub 2010 Nov 9
[PubMed PMID: 21062470]
[53]
Donohue JP, Zachary JM, Maynard BR. Distribution of nodal metastases in nonseminomatous testis cancer. The Journal of urology. 1982 Aug:128(2):315-20
[PubMed PMID: 7109099]
[54]
von Eyben FE. Laboratory markers and germ cell tumors. Critical reviews in clinical laboratory sciences. 2003 Aug:40(4):377-427
[PubMed PMID: 14582602]
[55]
Milose JC, Filson CP, Weizer AZ, Hafez KS, Montgomery JS. Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance. Open access journal of urology. 2011 Dec 30:4():1-8. doi: 10.2147/OAJU.S15063. Epub 2011 Dec 30
[PubMed PMID: 24198649]
[56]
Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, Fossa SD, Skakkebaek NE, de Wit R, Fizazi K, Droz JP, Pizzocaro G, Daugaard G, de Mulder PH, Horwich A, Oliver T, Huddart R, Rosti G, Paz Ares L, Pont O, Hartmann JT, Aass N, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Classen J, Clemm S, Culine S, de Wit M, Derigs HG, Dieckmann KP, Flasshove M, Garcia del Muro X, Gerl A, Germa-Lluch JR, Hartmann M, Heidenreich A, Hoeltl W, Joffe J, Jones W, Kaiser G, Klepp O, Kliesch S, Kisbenedek L, Koehrmann KU, Kuczyk M, Laguna MP, Leiva O, Loy V, Mason MD, Mead GM, Mueller RP, Nicolai N, Oosterhof GO, Pottek T, Rick O, Schmidberger H, Sedlmayer F, Siegert W, Studer U, Tjulandin S, von der Maase H, Walz P, Weinknecht S, Weissbach L, Winter E, Wittekind C, European Germ Cell Cancer Consensus Group. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Annals of oncology : official journal of the European Society for Medical Oncology. 2004 Sep:15(9):1377-99
[PubMed PMID: 15319245]
Level 3 (low-level) evidence
[57]
Dieckmann KP, Loy V. Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Dec:14(12):3126-32
[PubMed PMID: 8955658]
[58]
Albers P, Siener R, Kliesch S, Weissbach L, Krege S, Sparwasser C, Schulze H, Heidenreich A, de Riese W, Loy V, Bierhoff E, Wittekind C, Fimmers R, Hartmann M, German Testicular Cancer Study Group. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Apr 15:21(8):1505-12
[PubMed PMID: 12697874]
[59]
Groll RJ, Warde P, Jewett MA. A comprehensive systematic review of testicular germ cell tumor surveillance. Critical reviews in oncology/hematology. 2007 Dec:64(3):182-97
[PubMed PMID: 17644403]
Level 1 (high-level) evidence
[60]
Peckham MJ, Barrett A, Husband JE, Hendry WF. Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet (London, England). 1982 Sep 25:2(8300):678-80
[PubMed PMID: 6126625]
[61]
Chakiryan NH, Dahmen A, Cucchiara V, Briganti A, Montorsi F, Salonia A, Spiess PE, Necchi A. Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review. The Journal of urology. 2021 Jun:205(6):1569-1576. doi: 10.1097/JU.0000000000001685. Epub 2021 Feb 22
[PubMed PMID: 33617328]
[62]
Rustin GJ, Mead GM, Stenning SP, Vasey PA, Aass N, Huddart RA, Sokal MP, Joffe JK, Harland SJ, Kirk SJ, National Cancer Research Institute Testis Cancer Clinical Studies Group. Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197--the National Cancer Research Institute Testis Cancer Clinical Studies Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Apr 10:25(11):1310-5
[PubMed PMID: 17416851]
[63]
Gandini L, Sgrò P, Lombardo F, Paoli D, Culasso F, Toselli L, Tsamatropoulos P, Lenzi A. Effect of chemo- or radiotherapy on sperm parameters of testicular cancer patients. Human reproduction (Oxford, England). 2006 Nov:21(11):2882-9
[PubMed PMID: 16997940]
[64]
Huyghe E, Matsuda T, Daudin M, Chevreau C, Bachaud JM, Plante P, Bujan L, Thonneau P. Fertility after testicular cancer treatments: results of a large multicenter study. Cancer. 2004 Feb 15:100(4):732-7
[PubMed PMID: 14770428]
Level 2 (mid-level) evidence
[65]
Miki T, Mizutani Y, Nakamura T, Kawauchi A, Nagahara A, Nonomura N, Okuyama A. Post-chemotherapy nerve-sparing retroperitoneal lymph node dissection for advanced germ cell tumor. International journal of urology : official journal of the Japanese Urological Association. 2009 Apr:16(4):379-82. doi: 10.1111/j.1442-2042.2009.02251.x. Epub 2009 Feb 3
[PubMed PMID: 19191930]
[66]
Large MC, Sheinfeld J, Eggener SE. Retroperitoneal lymph node dissection: reassessment of modified templates. BJU international. 2009 Nov:104(9 Pt B):1369-75. doi: 10.1111/j.1464-410X.2009.08861.x. Epub
[PubMed PMID: 19840015]
[67]
Shayegan B, Carver BS, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour. BJU international. 2007 May:99(5):993-7
[PubMed PMID: 17437432]
[68]
Schirren J, Trainer S, Eberlein M, Lorch A, Beyer J, Bölükbas S. The role of residual tumor resection in the management of nonseminomatous germ cell cancer of testicular origin. The Thoracic and cardiovascular surgeon. 2012 Sep:60(6):405-12. doi: 10.1055/s-0031-1299584. Epub 2012 Mar 1
[PubMed PMID: 22383152]
[69]
Kollmannsberger C, Moore C, Chi KN, Murray N, Daneshmand S, Gleave M, Hayes-Lattin B, Nichols CR. Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy. Annals of oncology : official journal of the European Society for Medical Oncology. 2010 Jun:21(6):1296-1301. doi: 10.1093/annonc/mdp473. Epub 2009 Oct 29
[PubMed PMID: 19875756]
[70]
Arai Y, Kawakita M, Okada Y, Yoshida O. Sexuality and fertility in long-term survivors of testicular cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Apr:15(4):1444-8
[PubMed PMID: 9193338]
[71]
Jacobsen KD, Ous S, Waehre H, Trasti H, Stenwig AE, Lien HH, Aass N, Fosså SD. Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection. British journal of cancer. 1999 Apr:80(1-2):249-55
[PubMed PMID: 10390004]
[72]
Beck SD, Bey AL, Bihrle R, Foster RS. Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissection. The Journal of urology. 2010 Nov:184(5):2078-80. doi: 10.1016/j.juro.2010.06.146. Epub 2010 Sep 18
[PubMed PMID: 20850817]
[73]
Heidenreich A, Albers P, Hartmann M, Kliesch S, Kohrmann KU, Krege S, Lossin P, Weissbach L, German Testicular Cancer Study Group. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. The Journal of urology. 2003 May:169(5):1710-4
[PubMed PMID: 12686815]
[74]
Spitz A, Wilson TG, Kawachi MH, Ahlering TE, Skinner DG. Vena caval resection for bulky metastatic germ cell tumors: an 18-year experience. The Journal of urology. 1997 Nov:158(5):1813-8
[PubMed PMID: 9334609]
[75]
Beck SD, Lalka SG. Long-term results after inferior vena caval resection during retroperitoneal lymphadenectomy for metastatic germ cell cancer. Journal of vascular surgery. 1998 Nov:28(5):808-14
[PubMed PMID: 9808847]
[76]
Stephenson AJ, Sheinfeld J. Management of patients with low-stage nonseminomatous germ cell testicular cancer. Current treatment options in oncology. 2005 Sep:6(5):367-77
[PubMed PMID: 16107240]
[77]
Nicolai N, Miceli R, Artusi R, Piva L, Pizzocaro G, Salvioni R. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only. The Journal of urology. 2004 Jan:171(1):172-6
[PubMed PMID: 14665870]
[78]
Cullen MH, Stenning SP, Parkinson MC, Fossa SD, Kaye SB, Horwich AH, Harland SJ, Williams MV, Jakes R. Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Apr:14(4):1106-13
[PubMed PMID: 8648364]
[79]
Fischer S, Tandstad T, Wheater M, Porfiri E, Fléchon A, Aparicio J, Klingbiel D, Skrbinc B, Basso U, Shamash J, Lorch A, Dieckmann KP, Cohn-Cedermark G, Ståhl O, Chau C, Arriola E, Marti K, Hutton P, Laguerre B, Maroto P, Beyer J, Gillessen S. Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Jan 10:35(2):194-200
[PubMed PMID: 27893332]
[80]
Daugaard G, Gundgaard MG, Mortensen MS, Agerbæk M, Holm NV, Rørth M, von der Maase H, Christensen IJ, Lauritsen J. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Dec 1:32(34):3817-23. doi: 10.1200/JCO.2013.53.5831. Epub 2014 Sep 29
[PubMed PMID: 25267754]
[81]
Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JW. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer. 1998 Sep 1:83(5):1002-11
[PubMed PMID: 9731905]
[82]
Ehrlich Y, Baniel J. Late relapse of testis cancer. The Urologic clinics of North America. 2007 May:34(2):253-8; abstract x-xi
[PubMed PMID: 17484930]
[83]
Riedinger CB, Labbate C, Werntz RP, Eggener SE. Late Relapse of Nonseminomatous Germ Cell Tumor 24 Years Later. Urology. 2018 Dec:122():16-18. doi: 10.1016/j.urology.2018.08.014. Epub 2018 Aug 28
[PubMed PMID: 30170087]
[84]
Bokemeyer C, Nichols CR, Droz JP, Schmoll HJ, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Kanz L, Einhorn L, Hartmann JT. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Apr 1:20(7):1864-73
[PubMed PMID: 11919246]
[85]
Moran CA, Suster S, Koss MN. Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases. Cancer. 1997 Aug 15:80(4):699-707
[PubMed PMID: 9264353]
[86]
Ondrusova M, Suchansky M, Psota M, Zeleny T, Ondrus D. Late relapse in stage I of nonseminomatous germ cell testicular cancer on surveillance. Bratislavske lekarske listy. 2018:119(1):3-5. doi: 10.4149/BLL_2018_001. Epub
[PubMed PMID: 29405722]
[87]
Fizazi K, Culine S, Droz JP, Kramar A, Théodore C, Ruffié P, Le Chevalier T. Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Feb:16(2):725-32
[PubMed PMID: 9469363]
[88]
Ganjoo KN, Rieger KM, Kesler KA, Sharma M, Heilman DK, Einhorn LH. Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors. Cancer. 2000 Mar 1:88(5):1051-6
[PubMed PMID: 10699894]
[89]
International Prognostic Factors Study Group, Lorch A, Beyer J, Bascoul-Mollevi C, Kramar A, Einhorn LH, Necchi A, Massard C, De Giorgi U, Fléchon A, Margolin KA, Lotz JP, Germa Lluch JR, Powles T, Kollmannsberger CK. Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Nov 20:28(33):4906-11. doi: 10.1200/JCO.2009.26.8128. Epub 2010 Oct 18
[PubMed PMID: 20956623]
[90]
Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J, Dearnaley DP. Cardiovascular disease as a long-term complication of treatment for testicular cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Apr 15:21(8):1513-23
[PubMed PMID: 12697875]
[91]
Sakamoto H, Oohta M, Inoue K, Fuji K, Fukagai T, Yoshida H. Testicular sperm extraction in patients with persistent azoospermia after chemotherapy for testicular germ cell tumor. International journal of urology : official journal of the Japanese Urological Association. 2007 Feb:14(2):167-70
[PubMed PMID: 17302578]
[92]
Schmidt KL, Carlsen E, Andersen AN. Fertility treatment in male cancer survivors. International journal of andrology. 2007 Aug:30(4):413-8; discussion 418-9
[PubMed PMID: 17573855]
[93]
. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Feb:15(2):594-603
[PubMed PMID: 9053482]
Level 3 (low-level) evidence
[94]
Pagliaro LC. Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Apr 1:35(10):1036-1040. doi: 10.1200/JCO.2016.70.6523. Epub 2016 Dec 19
[PubMed PMID: 27992270]
[95]
Masterson TA, Shayegan B, Carver BS, Bajorin DF, Feldman DR, Motzer RJ, Bosl GJ, Sheinfeld J. Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer. Urology. 2012 Jan:79(1):156-9. doi: 10.1016/j.urology.2011.09.038. Epub
[PubMed PMID: 22202548]